WO2007045407A3 - Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma - Google Patents

Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma Download PDF

Info

Publication number
WO2007045407A3
WO2007045407A3 PCT/EP2006/009926 EP2006009926W WO2007045407A3 WO 2007045407 A3 WO2007045407 A3 WO 2007045407A3 EP 2006009926 W EP2006009926 W EP 2006009926W WO 2007045407 A3 WO2007045407 A3 WO 2007045407A3
Authority
WO
WIPO (PCT)
Prior art keywords
retinopathies
nutraceutical
glaucoma
prevention
treatment
Prior art date
Application number
PCT/EP2006/009926
Other languages
French (fr)
Other versions
WO2007045407A2 (en
Inventor
Massimo Ronchetti
Original Assignee
Artmed S R L
Massimo Ronchetti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20051968 external-priority patent/ITMI20051968A1/en
Priority claimed from IT001969A external-priority patent/ITMI20051969A1/en
Application filed by Artmed S R L, Massimo Ronchetti filed Critical Artmed S R L
Priority to EP06806269A priority Critical patent/EP1951071A2/en
Publication of WO2007045407A2 publication Critical patent/WO2007045407A2/en
Publication of WO2007045407A3 publication Critical patent/WO2007045407A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to nutraceutical and pharmaceutical compositions containing choline, unsaturated fatty acids and optionally antioxidants useful as adjuvants in the prevention and treatment of retinopathies (ARMD, diabetic retinopathy, etc.) and glaucoma.
PCT/EP2006/009926 2005-10-18 2006-10-13 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma WO2007045407A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06806269A EP1951071A2 (en) 2005-10-18 2006-10-13 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI2005A001968 2005-10-18
ITMI20051968 ITMI20051968A1 (en) 2005-10-18 2005-10-18 COLINA-BASED NEUTRACEUTICAL COMPOSITIONS IN THE PREVENTION AND TREATMENT OF GLAUCOMA
ITMI2005A001969 2005-10-18
IT001969A ITMI20051969A1 (en) 2005-10-18 2005-10-18 CHINA-BASED NEUTRACEUTICAL COMPOSITIONS GIVEN IN THE PREVENTION AND TREATMENT OF MACULAR DEGENERATION AND RETINOPATHIES

Publications (2)

Publication Number Publication Date
WO2007045407A2 WO2007045407A2 (en) 2007-04-26
WO2007045407A3 true WO2007045407A3 (en) 2007-07-26

Family

ID=37806145

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/009926 WO2007045407A2 (en) 2005-10-18 2006-10-13 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma

Country Status (2)

Country Link
EP (1) EP1951071A2 (en)
WO (1) WO2007045407A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20120284A1 (en) * 2012-06-18 2013-12-19 Omikron Italia S R L CITICOLINE FOR THE TREATMENT OF DIABETIC RETINOPATHY.

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015717A1 (en) * 1992-02-17 1993-08-19 Ciba-Geigy Ag Compositions for the treatment of glaucoma
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
WO2001084961A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
WO2002102394A2 (en) * 2001-06-18 2002-12-27 Neptune Technologies & Bioressources Inc. Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
EP1275399A2 (en) * 2001-07-09 2003-01-15 N.V. Nutricia Method and preparation for preventing and/or treating vascular disorders and secondary disorders associated therewith
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US20030044472A1 (en) * 2001-08-28 2003-03-06 Dexgen-Intellectual Property, Homocysteine, Inc. Method and synergistic composition for treating attention deficit/hyperactivity disorder
WO2004082402A1 (en) * 2003-03-18 2004-09-30 Novartis Ag Compositions comprising fatty acids and amino acids
WO2005037262A1 (en) * 2003-10-22 2005-04-28 Tubilux Pharma S.P.A. Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
US20050180989A1 (en) * 2004-02-12 2005-08-18 Kenichi Matsunaga Antihyperlipidemic agent and food
US20050180990A1 (en) * 2004-02-12 2005-08-18 Kenichi Matsunaga Antidiabetic agent and food

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015717A1 (en) * 1992-02-17 1993-08-19 Ciba-Geigy Ag Compositions for the treatment of glaucoma
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
WO2001084961A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
WO2002102394A2 (en) * 2001-06-18 2002-12-27 Neptune Technologies & Bioressources Inc. Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
EP1275399A2 (en) * 2001-07-09 2003-01-15 N.V. Nutricia Method and preparation for preventing and/or treating vascular disorders and secondary disorders associated therewith
US20030044472A1 (en) * 2001-08-28 2003-03-06 Dexgen-Intellectual Property, Homocysteine, Inc. Method and synergistic composition for treating attention deficit/hyperactivity disorder
WO2004082402A1 (en) * 2003-03-18 2004-09-30 Novartis Ag Compositions comprising fatty acids and amino acids
WO2005037262A1 (en) * 2003-10-22 2005-04-28 Tubilux Pharma S.P.A. Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
US20050180989A1 (en) * 2004-02-12 2005-08-18 Kenichi Matsunaga Antihyperlipidemic agent and food
US20050180990A1 (en) * 2004-02-12 2005-08-18 Kenichi Matsunaga Antidiabetic agent and food

Also Published As

Publication number Publication date
EP1951071A2 (en) 2008-08-06
WO2007045407A2 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2007016093A3 (en) Peroxide removal from drug delivery vehicle
WO2006002909A3 (en) Sphingolipids against pathological processes in lipid rafts
WO2007044693A3 (en) Multi-functional ionic liquid compositions
WO2006127832A3 (en) Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
RS20070305A (en) Formulations in the form of foam as modificators of immune response foamlike formulations as immunity modificators
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
EP2508523A3 (en) Polymorphs of dasatinib and process for preparation thereof
WO2007144317A3 (en) Vaccine
WO2008002121A3 (en) A self-emulsifying composition for poorly bioavailable drugs
WO2008058547A3 (en) Alpha-lactalbumin composition
BR112012005768A2 (en) An anti-overweight agent, food and drinks for anti-overweight, a glucose tolerance improvement agent, and food and drinks for a glucose tolerance improvement
WO2007127273A3 (en) Methods and compositions for altering cell function
MY138708A (en) Biaryloxymethylarenecarboxylic acids
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2007121352A3 (en) Therapeutic triterpenoids
EP3381445A3 (en) Aqueous formulation of antibody stablised by antioxidants for parenteral administration
WO2010136900A3 (en) Methods of using krill oil to treat risk factors for metabolic disorders and obesity
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
ATE452120T1 (en) FATTY ACID BENZENEDIOL DERIVATIVES AND PRODUCTION AND USE PROCESSES THEREOF
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
WO2006103638A3 (en) Topical pharmaceutical compositions of terbinafine and processes for their preparation
MX2010004899A (en) Novel neurturin conjugates for pharmaceutical use.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006806269

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006806269

Country of ref document: EP